迷走神经刺激市场规模、份额和成长分析（按产品类型、应用、生物材料、最终用户和地区）- 产业预测 2025-2032

迷走神经刺激市场规模在 2023 年价值 5.0799 亿美元，预计将从 2024 年的 5.5015 亿美元增长到 2032 年的 10.4115 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.3%。

迷走神经刺激 (VNS) 市场正在经历强劲增长，这归因于几个关键因素，包括老年人口的增长、技术进步以及对 VNS 作为癫痫和偏头痛等慢性病的辅助性治疗的需求不断增长。该设备的有效性（可使癫痫发作减少 50%）以及在治疗慢性忧郁症中的应用对于加强未来六年的市场动态至关重要。 2020 年，与疫情相关的医院准入限製造成了挫折，但远距会诊的兴起有助于减轻这些影响。此外，神经系统疾病的高发性和微创手术的趋势进一步凸显了 VNS 市场的潜力，并凸显了 VNS 在解决全球重大未满足的医疗需求方面的关键作用。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

迷走神经刺激市场规模（依产品类型）

• 市场概况
• 植入式迷走神经刺激装置
• 外部 VNS 设备

迷走神经刺激市场规模（依应用）

• 市场概况
• 癫痫
• 忧郁症
• 偏头痛
• 其他的

迷走神经刺激市场规模（依生物材料划分）

• 市场概况
• 金属
• 陶瓷
• 其他的

迷走神经刺激市场规模（依最终用户划分）

• 市场概况
• 医院
• 专科门诊
• 门诊手术中心

迷走神经刺激市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• LivaNova PLC（UK）
• ElectroCore, Inc.（USA）
• Cyberonics, Inc.（USA）
• Boston Scientific Corporation（USA）
• Medtronic PLC（Ireland）
• NeuroPace, Inc.（USA）
• Aleva Neurotherapeutics SA（Switzerland）
• BioControl Medical（Israel）
• Inspire Medical Systems, Inc.（USA）
• Nervana, LLC（USA）
• ReShape Lifesciences Inc.（USA）
• SetPoint Medical（USA）
• Soterix Medical Inc.（USA）
• tVNS Technologies GmbH（Germany）
• Parasym Ltd.（UK）
• Cerbomed GmbH（Germany）
• MicroTransponder Inc.（USA）
• NeuroSigma, Inc.（USA）
• BioElectronics Corporation（USA）
• Nexstim Plc（Finland）

结论和建议

Vagus Nerve Stimulation Market size was valued at USD 507.99 million in 2023 and is poised to grow from USD 550.15 million in 2024 to USD 1041.15 million by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The vagus nerve stimulation (VNS) market is experiencing robust growth driven by several key factors, including the increasing elderly population, advancements in technology, and a rising demand for VNS as an adjunct therapy for chronic conditions like epilepsy and migraines. The devices' effectiveness, evidenced by a 50% reduction in epileptic seizures, combined with their application in chronic depression treatment, are pivotal in enhancing market dynamics over the next six years. Despite setbacks in 2020 due to pandemic-related hospital access restrictions, the rise of teleconsultations has helped mitigate these impacts. Additionally, the high prevalence of neurological disorders and the trend toward minimally invasive procedures further underscore the VNS market's potential, highlighting its significant role in addressing critical unmet medical needs globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vagus Nerve Stimulation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vagus Nerve Stimulation Market Segments Analysis

Global Vagus Nerve Stimulation Market is segmented by Product Type, Application, Biomaterial, End User and region. Based on Product Type, the market is segmented into Implantable VNS Devices and External VNS Devices. Based on Application, the market is segmented into Epilepsy, Depression, Migraine and Others. Based on Biomaterial, the market is segmented into Metallic, Ceramics and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Vagus Nerve Stimulation Market

The increasing number of elderly individuals, who are more vulnerable to a range of neurological disorders, is significantly fueling the demand for advanced treatment solutions such as Vagus Nerve Stimulation (VNS). This innovative therapy offers hope for improving the quality of life for patients suffering from these conditions. As the elderly population continues to expand, the necessity for effective treatments that address their specific health challenges becomes crucial, thereby propelling the growth of the VNS market. This trend highlights the urgent need for novel medical interventions tailored to enhance the well-being of older adults facing neurological issues.

Restraints in the Vagus Nerve Stimulation Market

The Vagus Nerve Stimulation (VNS) market faces significant constraints due to the high costs associated with implantation procedures and the ongoing maintenance of the devices. These financial burdens can create affordability issues for patients, particularly those who may not have adequate insurance coverage or financial resources. Furthermore, healthcare systems may also struggle to allocate funds for such expensive treatments, which could limit accessibility for a broader patient population. As a result, the high expenses associated with VNS could hinder its adoption and utilization, impacting market growth and patient outcomes in the long term.

Market Trends of the Vagus Nerve Stimulation Market

The Vagus Nerve Stimulation (VNS) market is experiencing a notable trend towards non-invasive solutions, as advancements in technology yield devices that are more accessible and patient-friendly. This shift addresses longstanding concerns surrounding invasive procedures, making VNS therapy a viable option for a broader range of patients, including those who may be hesitant to undergo surgical interventions. The increasing awareness of the benefits of VNS, coupled with growing incidences of conditions such as epilepsy and depression, is driving demand. This trend is expected to foster innovation and competition, ultimately enhancing treatment options and improving patient outcomes in the thriving VNS market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Vagus Nerve Stimulation Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Implantable VNS Devices
• External VNS Devices

Global Vagus Nerve Stimulation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Epilepsy
• Depression
• Migraine
• Others

Global Vagus Nerve Stimulation Market Size by Biomaterial & CAGR (2025-2032)

• Market Overview
• Metallic
• Ceramics
• Others

Global Vagus Nerve Stimulation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

Global Vagus Nerve Stimulation Market Size & CAGR (2025-2032)

• North America (Product Type, Application, Biomaterial, End User)
  • US
  • Canada
• Europe (Product Type, Application, Biomaterial, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Biomaterial, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Biomaterial, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Biomaterial, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ElectroCore, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyberonics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aleva Neurotherapeutics SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioControl Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inspire Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nervana, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReShape Lifesciences Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SetPoint Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soterix Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• tVNS Technologies GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parasym Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerbomed GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTransponder Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioElectronics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexstim Plc (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations